An Examination of a Novel Weight Loss Supplement on Anthropometry and Indices of Cardiovascular Disease Risk by Ryan J. Sowinski (9280085)

A non-equilibrium slurry model of the F-layer above the inner core boundary by Andrew Walker (411843)

Supplementary Material for: Peripheral Retinal Imaging Biomarkers for Alzheimer’s Disease: A Pilot Study by Csincsik L. (5063666)

Regulation by a shared sRNA synchronizes the temporal induction of mRNA expression. by Jörn Matthias Schmiedel (141779)

“…The heatmaps show simulation results for a regulatory scenario where a coordinate, step-like increase (C) or decrease (panel D) in both mRNA synthesis rates is accompanied by a step-like change in the sRNA synthesis rate in the opposite direction; this counter-regulation assumption was necessary to eliminate delay phases, and to obtain the same steady states in sRNA and sRNA-less systems. …”

Effects of varying RU486 exposure time on Aβ42 levels and toxicity. by Iain Rogers (152860)

“…(B) Soluble and insoluble Arctic Aβ42 was fractionated (see methods) and measured by ELISA at the indicated time-points (n = 3). …”

<i>Bs</i>Fra alters the H/D exchange of <i>Bs</i>SufS and <i>Bs</i>SufU upon binding the <i>Bs</i>SufS/<i>Bs</i>SufU complex. by Bastian Blauenburg (715579)

“…Changes in <b>(F)</b> the SufU α5-helix and <b>(G)</b> the Cys41-loop as a function of deuterium uptake over time. …”

Supplemental Figure 10 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity by Dong Joon Kim (280038)

“…Vehicle, herbacetin (100 mg/kg B.W. p.o. or 2 mg/kg B.W. i.p.) or DFMO (1 g/kg B.W. p.o.) was administered by gavage or intraperitoneal injection 5 times per week for 5 weeks. (A) DFMO significantly decreased hearing (measured as prepulse inhibition or PPI) on day 35. …”

Myopia Progression during the COVID-19 Era: A Systematic Review and Meta-analysis by Mohammad Javad Najafzadeh (8873153)

Molecular dynamics simulation of the heart type fatty acid binding protein in a crystal environment by Yanis R. Espinosa (8961953)

Sleep-promoting <i>R23E10</i> neurons respond to AstA. by Stephane Dissel (669593)

“…(<b>J”</b>) A merge image. (<b>K</b>) Single optical section (0.5 μm) of a <i>R23E10-LexA>LexAop-GFP</i>, <i>AstA-GAL4>UAS-RFP</i> fly brain stained with anti-GFP (<b>K’</b>) Anti-RFP (magenta). …”

T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab by Usha Bughani (4220698)

Fat mass loss survival curve by age during inpatient treatment. by Domingos L. S. Rios (20496173)

Weight loss survival curve by age during inpatient treatment. by Domingos L. S. Rios (20496173)

Table_1_Giant cell temporal arteritis: a clinicopathological study with emphasis on unnecessary biopsy.pdf by Hind M. Alkatan (11592654)

“…In the group with positive TA biopsies, the mean age was 71 ± 8.4 years with a higher female predominance (female-to-male ratio of 5:3). …”

Plasma amino acids and metabolic profiling of dairy cows in response to a bolus duodenal infusion of leucine by Hassan Sadri (771911)

“…The elevation of plasma Leu concentrations after the infusion led to a significant decrease (<i>P</i><0.05) in the plasma concentrations of isoleucine, valine, glycine, and alanine. …”

Data_Sheet_1_Estimation of the economic impact of a bluetongue serotype 4 outbreak in Tunisia.docx by Ameni Ben Salem (18073126)

“…In cattle, exposure to BTV led to a daily unit milk yield decrease of 12.50 to 14.66 L over an average period of 5 months. …”

S1 Data - by Liaoxun Lu (179293)

Background frequency compensation in the oscillator of Fig 4. by Melissa Nygård (15374507)

Targeting ferroptosis: A novel therapeutic strategy for the treatment of mitochondrial disease-related epilepsy by Amanda H. Kahn-Kirby (5634986)

“…Cytoprotection was preceded by a dose-dependent decrease in general lipid oxidation and the specific 15-LO product 15-hydroxyeicosatetraenoic acid (15-HETE).…”

The Effect of Aromatherapy Alone or in Combination with Massage on Dysmenorrhea: A Systematic Review and Meta-analysis by Mona Najaf Najafi (6404132)